Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?
Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MWJ, van den Brink W, Moggi F, Møller M, van de Glind G. Skutle A, et al. Addict Behav Rep. 2015 Mar 28;2:13-18. doi: 10.1016/j.abrep.2015.03.001. eCollection 2015 Dec. Addict Behav Rep. 2015. PMID: 29531989 Free PMC article.
Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations.
Sánchez-Mora C, Ribasés M, Casas M, Bayés M, Bosch R, Fernàndez-Castillo N, Brunso L, Jacobsen KK, Landaas ET, Lundervold AJ, Gross-Lesch S, Kreiker S, Jacob CP, Lesch KP, Buitelaar JK, Hoogman M, Kiemeney LA, Kooij JJ, Mick E, Asherson P, Faraone SV, Franke B, Reif A, Johansson S, Haavik J, Ramos-Quiroga JA, Cormand B. Sánchez-Mora C, et al. Am J Med Genet B Neuropsychiatr Genet. 2011 Jul;156B(5):600-12. doi: 10.1002/ajmg.b.31202. Epub 2011 May 18. Am J Med Genet B Neuropsychiatr Genet. 2011. PMID: 21595008
Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.
Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F; IASP Research Group. Wapp M, et al. Eur Addict Res. 2015;21(4):188-94. doi: 10.1159/000371724. Epub 2015 Apr 1. Eur Addict Res. 2015. PMID: 25832736 Free PMC article.
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers.
Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MWJ, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W. Kaye S, et al. J Atten Disord. 2019 Oct;23(12):1438-1453. doi: 10.1177/1087054716629217. Epub 2016 Feb 27. J Atten Disord. 2019. PMID: 26922805 Free PMC article.
Attention-deficit/hyperactivity disorder.
Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Faraone SV, et al. Nat Rev Dis Primers. 2015 Aug 6;1:15020. doi: 10.1038/nrdp.2015.20. Nat Rev Dis Primers. 2015. PMID: 27189265 Review.
Meta-analysis of the DRD5 VNTR in persistent ADHD.
Klein M, Berger S, Hoogman M, Dammers J, Makkinje R, Heister AJGAM, Galesloot TE, Kiemeney LALM, Weber H, Kittel-Schneider S, Lesch KP, Reif A, Ribase S M, Ramos-Quiroga JA, Cormand B, Zayats T, Hegvik TA, Jacobsen KK, Johansson S, Haavik J, Mota NR, Bau CHD, Grevet EH, Doyle A, Faraone SV, Arias-Va Squez A, Franke B. Klein M, et al. Eur Neuropsychopharmacol. 2016 Sep;26(9):1527-1532. doi: 10.1016/j.euroneuro.2016.06.012. Epub 2016 Jul 29. Eur Neuropsychopharmacol. 2016. PMID: 27480019
Childhood trauma exposure in substance use disorder patients with and without ADHD.
Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MW, van den Brink W. Konstenius M, et al. Addict Behav. 2017 Feb;65:118-124. doi: 10.1016/j.addbeh.2016.10.016. Epub 2016 Oct 24. Addict Behav. 2017. PMID: 27816036 Free PMC article.
Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
Soler Artigas M, Sánchez-Mora C, Rovira P, Richarte V, Garcia-Martínez I, Pagerols M, Demontis D, Stringer S; ADHD Group of the Psychiatric Genomics Consortium, International Cannabis Consortium; Vink JM, Børglum AD, Neale BM, Franke B, Faraone SV, Casas M, Ramos-Quiroga JA, Ribasés M. Soler Artigas M, et al. Mol Psychiatry. 2020 Oct;25(10):2493-2503. doi: 10.1038/s41380-018-0339-3. Epub 2019 Jan 4. Mol Psychiatry. 2020. PMID: 30610198 Free PMC article.
340 results